Objective : Urological procedures are hazardous for hemophilic patients, Th
e aim of this work is to report the treatment of 22 hemophilic patients in
order to define prognosis factors and treatment options.
Material and Methods : 22 patients have been treated : 8 had severe hemophi
lia, 5 A (FVIII <1%), 3 B (F IX <1%), 2 had moderate hemophilia A (FVIII 2
to 6%) and 10 minor hemophilia A (F VIII 7 to 30%). Two had acquired hemoph
ilia with auto-anti-FVIII antibodies (ab). Four patients were HIV+. Eightee
n patients were first referred to our hospital, and 3 were transferred from
an other institution for persistent hematuria : one with anuria, one after
bladder neck incision, and the other following suprapubic prostatectomy.
Results : For patients without FVIII ab, a sufficient level of FVIII or IX
(>60%), could be achieved pre-operatively and maintained post operatively (
4 to 20 days, according to the surgical procedure) by injections of FVIII,
FIX or by injections of desmopressin.
For one haemophilia A patient with anti-F VIII ab, transferred for uncontro
llable bleeding after bladder neck incision, selective arterial embolizatio
n was successful.
But for 2 patients with acquired haemophilia, improvement of the coagulatio
n was insufficient, with human or porcine FVIII, activated prothombic compl
ex concentrates or recombinant activated FVII. In spite of surgical procedu
res and arterial embolizations the 2 patients died.
Conclusion : The urological treatment of haemophilic patients needs to be p
erformed in specialised centers. For patients without FVIII ab, classical u
rological procedures can be performed But for patients with FVIII ab when a
lternative treatments (radiotherapy, LNRH agonist) can be used, the surgica
l procedures must be delayed; in emergency if hemostasis cannot be achieved
arterial embolization could be useful.